Galectin Therapeutics Inc. (GALT)

[staccani]

I think GALT CX trial will fail as FX. Same dosage for a more advanced stage, guess what the result will be. Traber did not even bother to check what competition is doing and claims in his latest presentation that GALT is the only company with an active NASH Cirrhosis trial (nice , unfortunately it is not true, as CNAT has one ongoing and will have soon another one starting). I learned to mistrust Traber